mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Predictors of methadone program non-retention for opioid analgesic dependent patients

Cox J et al. – Understanding predictors of specific loss to follow–up outcomes may help methadone maintenance treatment programs improve patient retention.

Methods
  • Data were collected using the Addiction Severity Index Lite.
  • The probability of loss to follow-up was evaluated using a time-to-event analysis.
  • Involuntary and voluntary program discharges were treated separately as the outcomes of interest.
  • Multivariate Cox proportional hazards models were used to explore the role of various patient-related attributes.

Results
  • The probabilities of involuntary and voluntary discharges at 1 year were 20% and 14%, respectively.
  • In this exploratory analysis, determinants of loss to follow-up were characteristics related to drug use history (e.g., use of sedatives) and its consequences (e.g., number of lifetime arrests), and differed for each outcome.
  • Some determinants of involuntary discharge were modified by sex.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close